Spike Protein & Long COVID (PASC)

The correlation question

Long COVID (post-acute sequelae of SARS-CoV-2 infection, PASC) encompasses multi-system symptoms persisting months after acute illness. A parallel literature examines post-vaccination sequelae with overlapping symptom profiles. Some studies (Swank, Fehrer) report higher spike detection rates in symptomatic subsets; others find no consistent population-level correlation.

Symptom clusters

• Fatigue and post-exertional malaise
• Brain fog / cognitive dysfunction
• Cardiovascular (palpitations, myocarditis subsets)
• Neuropathy and autonomic dysfunction
• Dyspnea and exercise intolerance

Proposed mechanistic overlap

Shared hypotheses include endothelial dysfunction, fibrin-resistant microclots (S1 subunit), neuroinflammation, immune dysregulation, and tissue antigen reservoirs. Spike may act as a sustained trigger in some individuals while others clear antigen without sequelae.

NIH RECOVER & ongoing research

The NIH RECOVER Initiative and related trials (including SPEAR apheresis studies) are investigating biomarker-guided interventions. No spike-directed therapy is yet standard of care.